4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2022 - pmc.ncbi.nlm.nih.gov
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
Lifestyle interventions in nonalcoholic fatty liver disease
ZM Younossi, S Zelber-Sagi, L Henry… - Nature Reviews …, 2023 - nature.com
Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in
close association with metabolic irregularities. Between 2016 and 2019, the global …
close association with metabolic irregularities. Between 2016 and 2019, the global …
Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases
This is the first American Association for the Study of Liver Diseases (AASLD) practice
guidance on the management of malnutrition, frailty, and sarcopenia in patients with …
guidance on the management of malnutrition, frailty, and sarcopenia in patients with …
AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert …
ZM Younossi, KE Corey, JK Lim - Gastroenterology, 2021 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with
global public health impact affecting more than 25% of the global population. NAFLD is …
global public health impact affecting more than 25% of the global population. NAFLD is …
Sarcopenia and frailty in decompensated cirrhosis
In patients with decompensated cirrhosis, sarcopenia and frailty are prevalent. Although
several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly …
several definitions exist for these terms, in the field of hepatology, sarcopenia has commonly …
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
Acute-on-chronic liver failure clinical guidelines
In patients with cirrhosis and chronic liver disease, acute-on-chronic liver failure is emerging
as a major cause of mortality. These guidelines indicate the preferred approach to the …
as a major cause of mortality. These guidelines indicate the preferred approach to the …
Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
Objective To examine the effectiveness of green-Mediterranean (MED) diet, further restricted
in red/processed meat, and enriched with green plants and polyphenols on non-alcoholic …
in red/processed meat, and enriched with green plants and polyphenols on non-alcoholic …
Malnutrition in patients with liver cirrhosis
J Traub, L Reiss, B Aliwa, V Stadlbauer - Nutrients, 2021 - mdpi.com
Liver cirrhosis is an increasing public health threat worldwide. Malnutrition is a serious
complication of cirrhosis and is associated with worse outcomes. With this review, we aim to …
complication of cirrhosis and is associated with worse outcomes. With this review, we aim to …